Roger Daltrey, the iconic voice of The Who, has announced a new stop that will bring his 2026 solo tour to a close in Shelbyville, Delaware, on October 3. Ticket presales begin Wednesday at 10 a.m. local time, with general‑public sales opening Friday at the same hour.

The updated itinerary already includes a three‑night run at the Encore Theatre in Las Vegas, a September 9 performance at Nashville’s Ryman Auditorium, and a September 27 show at New York City’s Town Hall. The tour opened on August 23 in Mesa, Arizona, and is slated to finish in late September, with the full schedule posted on TheWho.com.

Daltrey will share the stage with a rotating group of special guests on select dates. Dan Bern, Jeffrey Gaines, Amy Helm, and Leslie Mendelson are slated to join him throughout the tour’s run.

When the tour first went live, Daltrey hinted that it might be his final solo outing. “Well it’s one more for the road,” he said. “After finishing The Who’s final tour of the U.S., it’s time for me as a solo artist to possibly do the same.” The remark follows The Who’s completion of their last North American tour in 2025.

The Delaware stop marks the tour’s final chapter, offering Mid‑Atlantic fans an intimate encounter with a veteran performer. The Encore Theatre, renowned for its acoustics and history of hosting major acts, will host the Las Vegas leg, while the Ryman Auditorium—once the home of the Grand Ole Opry—provides a historic backdrop for the Nashville date.

Daltrey’s set lists typically blend classic Who tracks, solo favorites, and rare covers, delivered with the powerful vocal presence that has defined his career. The addition of guest musicians adds a collaborative dimension that has become a hallmark of his recent shows.

Ticketing is straightforward: presales for the Delaware show start Wednesday at 10 a.m. local, with general‑public sales opening Friday at the same hour. Fans are encouraged to secure tickets early, as the venue’s capacity is limited and the artist’s popularity has historically driven quick sell‑outs.

The tour’s structure reflects a strategic use of venues that balance intimacy and prestige. The Encore Theatre’s three‑night stint provides a concentrated run in a city that is a major hub for touring acts, while the Ryman Auditorium’s single night offers a historic backdrop that resonates with both country and rock audiences.

Daltrey’s comments about a potential final tour are significant in the context of his career. After decades of touring with The Who and a parallel solo career that began in the early 1970s, the 2026 tour represents a culmination of his live‑performance legacy. The tour’s name, “A Great Night Out,” signals a personal, reflective approach to the set list and stage presentation.

In the broader music‑industry landscape, the tour’s timing aligns with a renewed interest in legacy acts touring in smaller venues, a trend that has been amplified by the pandemic‑era shift toward more intimate concert experiences. Daltrey’s choice of venues and guest artists reflects this shift, offering fans a curated, high‑quality live experience.

As the tour progresses, fans can follow the remaining dates through official channels, and ticket availability will be monitored closely. The addition of the Delaware stop ensures that the tour’s final chapter reaches a wider audience, closing a long‑running career that has spanned more than five decades.

The tour’s conclusion in late September leaves open the possibility of a final farewell performance, but no official statement has confirmed a definitive end to Daltrey’s solo touring. The upcoming shows, including the new Delaware date, will likely be the last opportunity for live audiences to experience his powerful vocals and dynamic stage presence in a solo context.